Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-23T13:54:43.562Z Has data issue: false hasContentIssue false

Teamwork, Cooperation, Innovation: Clues in the Canadian Success of Stroke Care

Published online by Cambridge University Press:  04 July 2016

Gustavo Saposnik*
Affiliation:
St. Michael's Hospital, University of Toronto, Toronto, Ontario, saposnikg@smh.toronto.on.ca
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © Canadian Neurological Sciences Federation 2009

References

1.Bogousslavsky, J, Pierre, P.Ischemic stroke in patients under age 45. Neurol Clin. 1992 Feb;10(1):113–24.CrossRefGoogle ScholarPubMed
2.Adams, HP Jr., del Zoppo, G, Alberts, MJ, Bhatt, DL, Brass, L, Furian, A, et al.Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May;38(5):1655–711.CrossRefGoogle ScholarPubMed
3.Wagner, JC, Lutsep, HL. Thrombolysis in young adults. J Thromb Thrombolysis. 2005 Oct;20(2): 133–6.Google Scholar
4.Poppe, A, Hill, M, AM, B. Intravenous thrombolysis for acute ischemic stroke in young adult patients. Can J Neurol Sci. 2009; 36:161–7.CrossRefGoogle Scholar
5.Hill, MD, Buchan, AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005 May 10; 172(10): 1307–12.Google Scholar
6.O'Donnell, MJ, Kapral, MK, Fang, J, Saposnik, G, Eikelboom, JW, Oczkowski, W, et al.Gastrointestinal bleeding after acute ischemic stroke. Neurology. 2008 Aug 26;71(9):650–5.Google Scholar
7.Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 Dec 14;333(24): 1581–7.Google Scholar
8.Ringleb, PA, Schellinger, PD, Schranz, C, Hacke, W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke. 2002 May;33(5): 1437–41.Google Scholar
9.Fiorelli, M, Bastianello, S, von Kummer, R, et al.Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999 Nov;30(11):2280–4.Google Scholar
10.Clark, WM, Wissman, S, Albers, GW, Jhamandas, JH, Madden, KP, Hamilton, S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Jama. 1999 Dec 1;282(21):2019–26.Google Scholar
11.Hacke, W, Kaste, M, Bluhmki, E, Brozman, M, Davalos, A, Guidetti, D, et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13): 1317–29.Google Scholar
12.Wahlgren, N, Ahmed, N, Davalos, A, Hacke, W, Milan, M, Muir, K, et al.Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008 Oct 11;372(9646): 1303–9.Google Scholar